Compositions containing alpha2-adrenergic agonist components

Details for Australian Patent Application No. 2005280259 (hide)

Owner Allergan, Inc.

Inventors Bakhit, Peter; Olejnik, Orest; Graham, Richard

Agent Davies Collison Cave

Pub. Number AU-A-2005280259

PCT Pub. Number WO2006/026215

Priority 10/928,906 27.08.04 US

Filing date 17 August 2005

Wipo publication date 9 March 2006

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/498 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

Event Publications

22 March 2007 PCT application entered the National Phase

  PCT publication WO2006/026215 Priority application(s): WO2006/026215

8 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005280266-Novel gene disruptions, compositions and methods relating thereto

2005280249-Liquid-filled chewing gum composition